APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Follicle Stimulating Hormone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Recombinant Follicle Stimulating Hormone Industry Growth and Trends Forecast to 2032

19 December 202595 pages

Choose your research edition.

Industry ResearchRecombinant Follicle Stimulating Hormone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Follicle Stimulating Hormone Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Recombinant Follicle Stimulating Hormone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Follicle Stimulating Hormone Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Follicle Stimulating Hormone Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Recombinant Follicle Stimulating Hormone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Follicle Stimulating Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Follicle Stimulating Hormone include Teva, MSD, Merck Serono, Techwell, GenSci and Gedeon Richter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Recombinant Follicle Stimulating Hormone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Recombinant Follicle Stimulating Hormone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Recombinant Follicle Stimulating Hormone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Recombinant Follicle Stimulating Hormone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Recombinant Follicle Stimulating Hormone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Recombinant Follicle Stimulating Hormone Market by Company

Teva

MSD

Merck Serono

Techwell

GenSci

Gedeon Richter

Recombinant Follicle Stimulating Hormone Segment by Type

75IU

150IU

Others

Recombinant Follicle Stimulating Hormone Segment by Application

Infertility Treatment

Assisted Reproductive Technology

Recombinant Follicle Stimulating Hormone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Follicle Stimulating Hormone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Follicle Stimulating Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Recombinant Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 75IU Table 2. Major Company of 150IU Table 3. Major Company of Others Table 4. Global Recombinant Follicle Stimulating Hormone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 6. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2021-2026) Table 7. Global Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 8. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2021-2026) Table 9. Global Recombinant Follicle Stimulating Hormone Price by Type (2021-2026) & (US$/Unit) Table 10. Global Recombinant Follicle Stimulating Hormone Sales by Type (2027-2032) & (K Units) Table 11. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2027-2032) Table 12. Global Recombinant Follicle Stimulating Hormone Sales by Type (2027-2032) & (US$ Million) Table 13. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2027-2032) Table 14. Global Recombinant Follicle Stimulating Hormone Price by Type (2027-2032) & (US$/Unit) Table 15. North America Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 16. North America Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 18. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 22. Latin America Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Type (2021-2026) & (US$ Million) Table 25. Recombinant Follicle Stimulating Hormone Industry Trends Table 26. Recombinant Follicle Stimulating Hormone Industry Drivers Table 27. Recombinant Follicle Stimulating Hormone Industry Opportunities and Challenges Table 28. Recombinant Follicle Stimulating Hormone Industry Restraints Table 29. Global Recombinant Follicle Stimulating Hormone Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Recombinant Follicle Stimulating Hormone Revenue Market Share by Company (2021-2026) Table 31. Global Recombinant Follicle Stimulating Hormone Sales by Company (2021-2026) & (K Units) Table 32. Global Recombinant Follicle Stimulating Hormone Sales Share by Company (2021-2026) Table 33. Global Recombinant Follicle Stimulating Hormone Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Recombinant Follicle Stimulating Hormone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Recombinant Follicle Stimulating Hormone Major Company Production Sites and Headquarters Table 36. Global Recombinant Follicle Stimulating Hormone Company, Product Type & Application Table 37. Global Recombinant Follicle Stimulating Hormone Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Recombinant Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Recombinant Follicle Stimulating Hormone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Recombinant Follicle Stimulating Hormone Sales by Region (2021-2026) & (K Units) Table 42. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2021-2026) Table 43. Global Recombinant Follicle Stimulating Hormone Sales by Region (2021-2026) & (US$ Million) Table 44. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2021-2026) Table 45. Global Recombinant Follicle Stimulating Hormone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Recombinant Follicle Stimulating Hormone Sales by Region (2027-2032) & (K Units) Table 47. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2027-2032) Table 48. Global Recombinant Follicle Stimulating Hormone Sales by Region (2027-2032) & (US$ Million) Table 49. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2027-2032) Table 50. Global Recombinant Follicle Stimulating Hormone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Recombinant Follicle Stimulating Hormone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 53. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2021-2026) Table 54. Global Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 55. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2021-2026) Table 56. Global Recombinant Follicle Stimulating Hormone Price by Application (2021-2026) & (US$/Unit) Table 57. Global Recombinant Follicle Stimulating Hormone Sales by Application (2027-2032) & (K Units) Table 58. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2027-2032) Table 59. Global Recombinant Follicle Stimulating Hormone Sales by Application (2027-2032) & (US$ Million) Table 60. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2027-2032) Table 61. Global Recombinant Follicle Stimulating Hormone Price by Application (2027-2032) & (US$/Unit) Table 62. North America Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 63. North America Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 65. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 69. Latin America Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Recombinant Follicle Stimulating Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Recombinant Follicle Stimulating Hormone Product Portfolio Table 76. Teva Recent Development Table 77. MSD Company Information Table 78. MSD Business Overview Table 79. MSD Recombinant Follicle Stimulating Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. MSD Recombinant Follicle Stimulating Hormone Product Portfolio Table 81. MSD Recent Development Table 82. Merck Serono Company Information Table 83. Merck Serono Business Overview Table 84. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolio Table 86. Merck Serono Recent Development Table 87. Techwell Company Information Table 88. Techwell Business Overview Table 89. Techwell Recombinant Follicle Stimulating Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Techwell Recombinant Follicle Stimulating Hormone Product Portfolio Table 91. Techwell Recent Development Table 92. GenSci Company Information Table 93. GenSci Business Overview Table 94. GenSci Recombinant Follicle Stimulating Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GenSci Recombinant Follicle Stimulating Hormone Product Portfolio Table 96. GenSci Recent Development Table 97. Gedeon Richter Company Information Table 98. Gedeon Richter Business Overview Table 99. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolio Table 101. Gedeon Richter Recent Development Table 102. North America Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 104. North America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 105. North America Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 107. North America Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Recombinant Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 110. North America Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Recombinant Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 112. Europe Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 114. Europe Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 115. Europe Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Recombinant Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 120. Europe Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Recombinant Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 130. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 132. Latin America Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 134. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 135. Latin America Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Recombinant Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 140. Latin America Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Recombinant Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Share by Country (2021-2026) Table 150. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Recombinant Follicle Stimulating Hormone Distributors List Table 155. Recombinant Follicle Stimulating Hormone Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Recombinant Follicle Stimulating Hormone Image Figure 2. Global Recombinant Follicle Stimulating Hormone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Follicle Stimulating Hormone Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Follicle Stimulating Hormone Sales (2021-2032) & (K Units) Figure 5. 75IU Image Figure 6. Global 75IU Sales YoY Growth (2021-2032) & (K Units) Figure 7. 150IU Image Figure 8. Global 150IU Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Recombinant Follicle Stimulating Hormone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Recombinant Follicle Stimulating Hormone Market Share by Type 2025 VS 2032 Figure 13. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 14. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 15. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 16. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 19. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Recombinant Follicle Stimulating Hormone Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Infertility Treatment Image Figure 26. Global Infertility Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 27. Assisted Reproductive Technology Image Figure 28. Global Assisted Reproductive Technology Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Recombinant Follicle Stimulating Hormone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Recombinant Follicle Stimulating Hormone Market Share by Application 2025 VS 2032 Figure 31. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 32. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 33. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2025 Figure 41. North America Recombinant Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Recombinant Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Recombinant Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Recombinant Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Recombinant Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Recombinant Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Recombinant Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Recombinant Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Recombinant Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Recombinant Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Recombinant Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Recombinant Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Recombinant Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Recombinant Follicle Stimulating Hormone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Recombinant Follicle Stimulating Hormone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Recombinant Follicle Stimulating Hormone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 75IU
  • 150IU
  • Others
Applications
  • Infertility Treatment
  • Assisted Reproductive Technology
Companies covered
  • Teva
  • MSD
  • Merck Serono
  • Techwell
  • GenSci
  • Gedeon Richter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Follicle Stimulating Hormone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Recombinant Follicle Stimulating Hormone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Recombinant Follicle Stimulating Hormone Market by Type
  6. 1.3.1 75IU
  7. 1.3.2 150IU
  8. 1.3.3 Others
  9. 1.4 Global Recombinant Follicle Stimulating Hormone Market Size by Type
  10. 1.4.1 Global Recombinant Follicle Stimulating Hormone Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Recombinant Follicle Stimulating Hormone Industry Trends
  2. 2.2 Recombinant Follicle Stimulating Hormone Industry Drivers
  3. 2.3 Recombinant Follicle Stimulating Hormone Industry Opportunities and Challenges
  4. 2.4 Recombinant Follicle Stimulating Hormone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Recombinant Follicle Stimulating Hormone Revenue (2021-2026)
  2. 3.2 Global Top Players by Recombinant Follicle Stimulating Hormone Sales (2021-2026)
  3. 3.3 Global Top Players by Recombinant Follicle Stimulating Hormone Price (2021-2026)
  4. 3.4 Global Recombinant Follicle Stimulating Hormone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Follicle Stimulating Hormone Major Company Production Sites & Headquarters
  6. 3.6 Global Recombinant Follicle Stimulating Hormone Company, Product Type & Application
  7. 3.7 Global Recombinant Follicle Stimulating Hormone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Follicle Stimulating Hormone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Follicle Stimulating Hormone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Follicle Stimulating Hormone Tier 1, Tier 2, and Tier 3
4 Recombinant Follicle Stimulating Hormone Regional Status and Outlook
  1. 4.1 Global Recombinant Follicle Stimulating Hormone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size by Region
  3. 4.2.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Recombinant Follicle Stimulating Hormone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Recombinant Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Region
  7. 4.3.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Recombinant Follicle Stimulating Hormone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Recombinant Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Recombinant Follicle Stimulating Hormone by Application
  1. 5.1 Recombinant Follicle Stimulating Hormone Market by Application
  2. 5.1.1 Infertility Treatment
  3. 5.1.2 Assisted Reproductive Technology
  4. 5.2 Global Recombinant Follicle Stimulating Hormone Market Size by Application
  5. 5.2.1 Global Recombinant Follicle Stimulating Hormone Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Recombinant Follicle Stimulating Hormone Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 MSD
  8. 6.2.1 MSD Company Information
  9. 6.2.2 MSD Business Overview
  10. 6.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 MSD Recombinant Follicle Stimulating Hormone Product Portfolio
  12. 6.2.5 MSD Recent Developments
  13. 6.3 Merck Serono
  14. 6.3.1 Merck Serono Company Information
  15. 6.3.2 Merck Serono Business Overview
  16. 6.3.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Serono Recombinant Follicle Stimulating Hormone Product Portfolio
  18. 6.3.5 Merck Serono Recent Developments
  19. 6.4 Techwell
  20. 6.4.1 Techwell Company Information
  21. 6.4.2 Techwell Business Overview
  22. 6.4.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Techwell Recombinant Follicle Stimulating Hormone Product Portfolio
  24. 6.4.5 Techwell Recent Developments
  25. 6.5 GenSci
  26. 6.5.1 GenSci Company Information
  27. 6.5.2 GenSci Business Overview
  28. 6.5.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GenSci Recombinant Follicle Stimulating Hormone Product Portfolio
  30. 6.5.5 GenSci Recent Developments
  31. 6.6 Gedeon Richter
  32. 6.6.1 Gedeon Richter Company Information
  33. 6.6.2 Gedeon Richter Business Overview
  34. 6.6.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Product Portfolio
  36. 6.6.5 Gedeon Richter Recent Developments
7 North America by Country
  1. 7.1 North America Recombinant Follicle Stimulating Hormone Sales by Country
  2. 7.1.1 North America Recombinant Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 7.1.3 North America Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Recombinant Follicle Stimulating Hormone Market Size by Country
  6. 7.2.1 North America Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 7.2.3 North America Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Recombinant Follicle Stimulating Hormone Sales by Country
  2. 8.1.1 Europe Recombinant Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 8.1.3 Europe Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Recombinant Follicle Stimulating Hormone Market Size by Country
  6. 8.2.1 Europe Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Country
  2. 9.1.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size by Country
  6. 9.2.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Recombinant Follicle Stimulating Hormone Sales by Country
  2. 10.1.1 South America Recombinant Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 10.1.3 South America Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Recombinant Follicle Stimulating Hormone Market Size by Country
  6. 10.2.1 South America Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 10.2.3 South America Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country
  2. 11.1.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size by Country
  6. 11.2.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Recombinant Follicle Stimulating Hormone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Recombinant Follicle Stimulating Hormone Value Chain Analysis
  2. 12.1.1 Recombinant Follicle Stimulating Hormone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Recombinant Follicle Stimulating Hormone Production Mode & Process
  7. 12.2 Recombinant Follicle Stimulating Hormone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Recombinant Follicle Stimulating Hormone Distributors
  10. 12.2.3 Recombinant Follicle Stimulating Hormone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst